Page last updated: 2024-08-23

amikacin and Infections, Serratia

amikacin has been researched along with Infections, Serratia in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (16.67)18.2507
2000's4 (66.67)29.6817
2010's1 (16.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bosman, N; Chibabhai, V; Lowman, W; Nana, T; Thomas, T1
Hashemian, MN; Khodabande, A; Rahimi, F1
Bégué, T; Bouchaud, O; Jauréguy, F; Lefort, A; Lortholary, O; Righi, S; Robineau, M1
Cheng, KC; Chuang, YC; Huang, GC; Wu, LT; Yu, WL1
Diniz, EM; Fontes, RB; Hirooka, TM; Matushita, H; Pinto, FC1
Baron, D; Bugnon, D; Caillon, J; Drugeon, H; Kergueris, MF; Le Conte, P; Potel, G; Xiong, YQ1

Reviews

2 review(s) available for amikacin and Infections, Serratia

ArticleYear
Were all carbapenemases created equal? Treatment of NDM-producing extensively drug-resistant Enterobacteriaceae: a case report and literature review.
    Infection, 2018, Volume: 46, Issue:1

    Topics: Amikacin; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Child; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; Meropenem; Serratia Infections; Serratia marcescens; Thienamycins; Treatment Outcome

2018
Cerebral abscess caused by Serratia marcescens in a premature neonate.
    Arquivos de neuro-psiquiatria, 2007, Volume: 65, Issue:4A

    Topics: Amikacin; Anti-Bacterial Agents; Brain Abscess; Diseases in Twins; Humans; Infant, Newborn; Male; Meropenem; Serratia Infections; Serratia marcescens; Thienamycins

2007

Other Studies

4 other study(ies) available for amikacin and Infections, Serratia

ArticleYear
Serratia marcescens keratitis after photorefractive keratectomy.
    Journal of cataract and refractive surgery, 2009, Volume: 35, Issue:9

    Topics: Adult; Amikacin; Anti-Bacterial Agents; Ceftazidime; Contact Lenses, Hydrophilic; Corneal Ulcer; Drug Therapy, Combination; Equipment Contamination; Eye Infections, Bacterial; Female; Humans; Myopia; Photorefractive Keratectomy; Postoperative Complications; Serratia Infections; Serratia marcescens

2009
Serratia marcescens prosthesis infection successfully treated with meropenem after imipenem failure.
    The Journal of infection, 2005, Volume: 51, Issue:2

    Topics: Aged; Amikacin; Anti-Bacterial Agents; Arthroplasty, Replacement, Knee; Drug Resistance, Bacterial; Female; Humans; Imipenem; Knee Prosthesis; Meropenem; Prosthesis-Related Infections; Serratia Infections; Serratia marcescens; Thienamycins; Treatment Failure; Treatment Outcome

2005
Clinical experiences of the infections caused by extended-spectrum beta-lactamase-producing Serratia marcescens at a medical center in Taiwan.
    Japanese journal of infectious diseases, 2006, Volume: 59, Issue:3

    Topics: Amikacin; beta-Lactamase Inhibitors; beta-Lactamases; Carbapenems; Cefepime; Cephalosporins; Electrophoresis, Gel, Pulsed-Field; Humans; Imipenem; Microbial Sensitivity Tests; Molecular Epidemiology; Molecular Sequence Data; Polymerase Chain Reaction; Serratia Infections; Serratia marcescens; Taiwan

2006
In vivo antibacterial effects of simulated human serum profiles of once-daily versus thrice-daily dosing of amikacin in a Serratia marcescens endocarditis experimental model.
    Antimicrobial agents and chemotherapy, 1996, Volume: 40, Issue:5

    Topics: Amikacin; Animals; Anti-Bacterial Agents; Drug Administration Schedule; Endocarditis, Bacterial; Female; Infusions, Intravenous; Models, Biological; Rabbits; Serratia Infections; Serratia marcescens

1996